Patrick Zenner Net Worth

The estimated Net Worth of Patrick J Zenner is at least $37.4 Million dollars as of 24 September 2019. Mr. Zenner owns over 25,000 units of West Pharmaceutical Services stock worth over $36,952,008 and over the last 21 years he sold WST stock worth over $0. In addition, he makes $444,291 as Independent Chairman of the Board at West Pharmaceutical Services.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Zenner WST stock SEC Form 4 insiders trading

Patrick has made over 20 trades of the West Pharmaceutical Services stock since 2008, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of WST stock worth $153,500 on 24 September 2019.

The largest trade he's ever made was exercising 25,000 units of West Pharmaceutical Services stock on 24 September 2019 worth over $153,500. On average, Patrick trades about 1,684 units every 40 days since 2003. As of 24 September 2019 he still owns at least 122,216 units of West Pharmaceutical Services stock.

You can see the complete history of Mr. Zenner stock trades at the bottom of the page.

Patrick Zenner biography

Patrick J. Zenner serves as Independent Chairman of the Board of the Company. Mr. Zenner was first elected Chair of the Board effective July 1, 2015. He retired from Hoffmann-La Roche Inc., North America—the prescription drug unit of the Roche Group, a leading research-based healthcare enterprise—in 2001, where he served as President and CEO from 1993 to 2001. He served as Interim CEO of CuraGen Corporation from May 2005 through March 2006. Since then, Mr. Zenner was a director and Chair of the Board of Exact Sciences Corporation until July 2010 and served as its Interim CEO from July 2007 to March 2008. Mr. Zenner served as Chair of the Board of ArQule, Inc. until its acquisition in January 2020, and he also serves as a director of Selecta Biosciences, Inc. Mr. Zenner is currently a member of the Board of Trustees of Creighton University and is Chair of the Board of Trustees of Fairleigh Dickinson University.

What is the salary of Patrick Zenner?

As the Independent Chairman of the Board of West Pharmaceutical Services, the total compensation of Patrick Zenner at West Pharmaceutical Services is $444,291. There are 10 executives at West Pharmaceutical Services getting paid more, with Eric Green having the highest compensation of $6,533,690.

How old is Patrick Zenner?

Patrick Zenner is 73, he's been the Independent Chairman of the Board of West Pharmaceutical Services since 2015. There are no older and 26 younger executives at West Pharmaceutical Services.

What's Patrick Zenner's mailing address?

Patrick's mailing address filed with the SEC is C/O SELECTA BIOSCIENCES, INC., 65 GROVE STREET, WATERTOWN, MA, 02472.

Insiders trading at West Pharmaceutical Services

Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci und Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.

What does West Pharmaceutical Services do?

west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.

Complete history of Mr. Zenner stock trades at Exact Sciences, Geron, Selecta Biosciences Inc, XOMA Royalty und West Pharmaceutical Services

West Pharmaceutical Services executives and stock owners

West Pharmaceutical Services executives and other stock owners filed with the SEC include:

• Eric Green,
  President, Chief Executive Officer, Director
• Eric M. Green,
  Pres, CEO & Director
• Bernard Birkett,
  Chief Financial Officer, Senior Vice President
• George Miller,
  Senior Vice President, General Counsel, Corporate Secretary
• Bernard J. Birkett,
  Sr. VP & CFO
• Silji Abraham,
  Senior Vice President and Chief Digital and Transformation Officer
• David Montecalvo,
  Senior Vice President, Chief Operating and Supply Chain Officer
• Annette Favorite,
  Chief Human Resource Officer, Senior Vice President
• David A. Montecalvo,
  Sr. VP and Chief Operations & Supply Chain Officer
• Silji Abraham,
  Sr. VP & Chief Technology Officer
• Patrick Zenner,
  Independent Chairman of the Board
• Douglas Michels,
  Independent Director
• Thomas Hofmann,
  Independent Director
• Paula Johnson,
  Independent Director
• William Feehery,
  Independent Director
• Mark Buthman,
  Independent Director
• Myla Lai-Goldman,
  Independent Director
• Paolo Pucci,
  Independent Director
• Deborah Keller Tanner,
  Independent Director
• Chad Winters,
  Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller
• Robert Friel,
  Independent Director
• Cindy Reiss-Clark,
  Senior Vice President of Global Market Units and Commercial Solutions
• Quintin Lai,
  Vice President - Corporate Development, Strategy and Investor Relations
• Eric Resnick,
  Chief Technology Officer, Vice President
• Richard D. Luzzi,
  Sr. VP of HR
• Annette F. Favorite,
  Chief HR Officer & Sr. VP
• Michele Polinsky,
  VP of Global Communications
• Kimberly Banks MacKay,
  Sr. VP, Gen. Counsel & Company Sec.
• Dr. Quintin J. Lai C.F.A., Ph.D.,
  VP of Strategy & Investor Relations
• Daniel Malone,
  Vice President & Controller
• William J Federici,
  VP & CFO
• John H Weiland,
  Director
• Karen Flynn,
  President, America's Region
• Heino Lennartz,
  President Europe
• Anthony Welters,
  Director
• Warwick Bedwell,
  VP Pharma Pkgs Systems Asia Pa
• John E Paproski,
  Vice President-Innovations
• Christopher G Ryan,
  President, PPS, Americas
• Rachael M Bushey,
  VP, Deputy Gen Coun & Corp Sec
• Jeffrey C Hunt,
  VP Pharma Pckg Systems
• John R Gailey,
  VP, Gen. Counsel & Sec.
• Richard D Luzzi,
  VP, Human Resourses
• L Robert Johnson,
  Director
• Michael A Anderson,
  Vice President & Treasurer
• Donald E Jr Morel,
  Chairman of the Board & CEO
• Robert C Young,
  Director
• Donald A Mc Millan,
  President Pharma Systems NA
• Steven A Ellers,
  Pres., Pharma. Systems Div.
• Geoffrey F Worden,
  Director
• John P Neafsey,
  Director
• Joseph E Abbott,
  Corporate Controller
• Dijk Ronald Van,
  President Asia Pacific
• Robert S Hargesheimer,
  President-The Tech Group
• Fabio De Sampaio Doria Filho,
  Pres., Europe & Asia Pacific
• Matthew T Mullarkey,
  Chief Operating Officer
• Robert J Keating,
  Pres., Europe & Asia Pacific
• Jenne K Britell,
  Director
• Herbert L Hugill,
  Pres. of the Americas, Pharma.
• Linda R Altemus,
  VP & Chief Compliance Officer
• Molly Joseph,
  Director
• Deborah L Keller,
  Director
• Stephen H Lockhart,
  Director
• Charles Witherspoon,
  VP & Treasurer
• Kimberly Banks Mac Kay,
  SVP, GC & Corporate Secretary